Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Alcohol-Mediated Renal Denervation Appears Safe for BP Reduction

Key clinical point: Delivered by injection, alcohol-based renal denervation was associated with efficacy and safety in pilot study.

Major finding: At six months, mean 24-hour ambulatory systolic blood pressure was reduced 11 mmHg.

Data Source: Open label study.

Disclosures: Dr. Sievert did not include Ablative Solutions, the developer of the Peregrine System Kit, on a list of pharmaceutical and device manufacturers with which he has financial relationships.

Citation:

2019 Cardiovascular Research Technologies.

This Week's Must Reads

CVD Event Rates Among Adults with PCSK9 Inhibition, Cardiovasc Drugs Ther; ePub 2019 Feb 11; Colantonio, et al

Statin Adherence & Mortality in Patients with ASCVD, JAMA Cardiol; ePub 2019 Feb 13; Rodriguez, et al

Physician Monitoring & LDL-C Follow-Up Testing , Prev Med; 2019 Apr; Dansinger, Williams, et al

CVD Prevalence in HeFH After Statin Treatment, Atherosclerosis; ePub 2019 Feb 12; Perez-Calahorra, et al

Must Reads in Hypertension

Antihypertensive Medications and Thrombolysis Therapy, J Clin Hypertens; ePub 2019 Jan 23; Fleming, et al

Admission BP & Outcomes in Patients with TIA, Am J Cardiol; ePub 2019 Jan 11; Bangalore, et al

Hypertension and ECG-LVH and CV Mortality, Am J Cardiol; ePub 2018 Oct 18; Cao, et al

Obtaining a Reliable Estimate of Home Blood Pressure, J Am Heart Assoc; ePub 2018 Oct 5; Bello, et al